Home/ Supplements/ Nattokinase/ Peak Blood Flow

Peak Blood Flow

product on market Capsule Peak Pure & Natural Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Peak Blood Flow
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mg
Market median: 100.0mg (70 products)

Other Ingredients

Vegetable Capsule Maltodextrin Hydroxypropyl Methylcellulose Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Adults take one (1) capsule daily, preferably with a meal, or as directed by a healthcare practitioner.

Warnings & Precautions

Do not exceed recommended dose. Do not use if clear neck seal is broken or missing.

If you are nursing, pregnant, taking medication or have a medical condition, consult your physician before taking this product.

Warning: Consult with your health care practitioner before taking this product if you take Coumadin (Warfarin) or other blood thinners.

Formulation Notes

100 mg Nattokinase

V (Vegetarian)

Non GMO GF (Gluten free)

Additional Information

Store at room temperature, in a dry place.

Clean label V (Vegetarian) Manufactured in U.S.A. with quality ingredients from around the world

Metadata

Product Details

DSLD Entry Date2025-07-24
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID333603
Data Updated2026-04-11
Research

Research Evidence

4
Research Sources
45
Avg Quality
2
Rct
1
Other
1
Systematic Review
B Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Systematic Review Reviews in cardiovascular medicine 2023 PubMed DOI
C Effects of nattokinase on blood pressure: a randomized, controlled trial
Rct Hypertension research : official journal of the Japanese Society of Hypertension 2008 PubMed DOI
C A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles
Rct Scientific reports 2015 PubMed DOI
D [A clinical study on the effect of nattokinase on carotid artery atherosclerosis and hyperlipidaemia]
Other Zhonghua yi xue za zhi 2017 PubMed DOI
View all evidence for Nattokinase →
Compare

Similar Products

View all Nattokinase products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.